In accordance, suppression of PRLR expression by shRNA reduced the growth, invasiveness and tumourigenicity of breast cancer T47D cells61, which highlights PRLR as a therapeutic target for breast cancer62,63. The gene discussed is PRLR; the disease is breast carcinoma.